Lataa...
Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by Z(HER2)-Idarubicin Conjugate: An in vitro Study
BACKGROUND & OBJECTIVE: Overexpression of human epidermal growth factor receptor 2 (HER2) causes cell transformation and development of various types of malignancies. Idarubicin is an effective anti-neoplastic drug but its specific delivery to the targeted cells is still a great challenge. Affib...
Tallennettuna:
| Julkaisussa: | Iran J Pathol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Iranian Society of Pathology
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8085286/ https://ncbi.nlm.nih.gov/pubmed/33936221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.30699/IJP.2020.120392.2310 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|